Legal entity
All 6 tracked stories fall under one category: regulation. Of the tracked stories, 3 of 6 also mention MMJ International Holdings, the most common co-covered peer. Source depth averages 2.3 original sources per story, versus 2.9 across the same-window beat baseline.
Last mentioned: Aug 16, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 6 tracked stories fall under one category: regulation. Of the tracked stories, 3 of 6 also mention MMJ International Holdings, the most common co-covered peer. Source depth averages 2.3 original sources per story, versus 2.9 across the same-window beat baseline. The 35-day window averages about 1.2 stories each week. The busiest single day carried 2. The negative share is 33%, the same as the 33% benchmark across 459 Legal stories in the same window. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window. Duane Boise appears in 6 tracked Legal stories published from July 13, 2026 through August 16, 2026.
Computed from the 6 stories linked to this entity, with beat comparisons drawn from all 459 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Duane Boise. Shared-story counts are live from our verified record — not editorial picks.
Post-Hearing Briefs Due
Parties submit final briefs to Administrative Law Judge Derek C. Julius, summarizing their arguments on the evidentiary record and legal standards. The recommendation on rescheduling is expected to follow shortly thereafter.
MMJ International Holdings issues legal warning
MMJ said that operational implementation of the administration's cannabis agenda does not equal legal finality and that its federal challenges could yield a stay, remand, vacatur, or targeted relief.
CNBC reports cannabis as emerging midterm issue
A CNBC report highlighted marijuana policy as an emerging 2026 midterm issue, noting ballot measures in Massachusetts and Idaho and gubernatorial races in Kansas and Iowa.
Senate Democrats reintroduce Cannabis Administration and Opportunity Act
17 Senate Democrats reintroduced the CAOA, maintaining federal cannabis reform pressure while administrative actions proceed.
Rescheduling Hearing Testimony
Under subpoena, Dr. Akinfiresoye testifies in the marijuana rescheduling proceeding that marijuana fails the first three factors of the DEA's five-factor test, directly contradicting the HHS Schedule III recommendation.
ALJ Hearing on Marijuana Rescheduling
A seven-day administrative hearing is held in Arlington, Virginia, debating whether marijuana has a 'currently accepted medical use' without MMJ's testimony or evidence.
DEA Excludes MMJ from Rescheduling Hearing
The DEA denies MMJ International Holdings' request to participate in the upcoming administrative hearing, asserting that its evidence raises only questions of law.
Attorney General orders marijuana moved to Schedule III
The AG issues an order rescheduling state‑licensed medical marijuana and establishing a novel federal registration system for state marijuana businesses.
DEA Scientific Data Review Published
Dr. Luli Akinfiresoye authors the DEA's internal Scientific Data Review on marijuana, reportedly concluding that marijuana lacks sufficient, reproducible scientific evidence for accepted medical use.
MMJ files DEA bulk‑manufacturer application
MMJ International Holdings submits an application to manufacture active pharmaceutical ingredients for cannabinoid drugs, which remains pending nearly eight years later.
For legal and regulatory professionals, MMJ's statement exposes the volatile gap between administrative implementation and judicial finality. The dispute could generate stay, remand, or vacatur rulings that determine whether operators can rely on current federal cannabis policies.
ALJ Julius's upcoming recommendation in the DEA marijuana rescheduling hearing may challenge the government's novel approach of limiting Schedule III status to state-licensed medical programs, after DEA scientist testimony cast doubt on whether such programs satisfy the Controlled Substances Act's rigorous medical-use standard.
Source: nashvilleherald.com · pittsburghstar.com
A D.C. Circuit review of the Attorney General’s April 2026 order moving medical marijuana to Schedule III puts administrative law front and center. MMJ International Holdings argues the AG skipped required rulemaking and evidentiary hearings, threatening the integrity of the Controlled Substances Act’s scheduling process.
DEA pharmacologist Dr. Luli Akinfiresoye testified that marijuana fails the agency's historical scientific standard for accepted medical use, directly contradicting the HHS recommendation to reschedule. This intra-agency conflict exposes the proposed Schedule III rule to a likely arbitrary-and-capricious challenge, redefining the evidentiary landscape for controlled substance rulemaking.
Source: newjerseytelegraph.com · pr-inside.com
The MMJ International Holdings petition raises fundamental administrative law questions: can an agency issue a final rescheduling order before conducting the hearing required by the Controlled Substances Act? The D.C. Circuit’s answer will shape DEA’s authority over all future scheduling actions.
MMJ International Holdings alleges the DEA violated administrative law by excluding it from marijuana rescheduling hearings, despite spending $10 million on FDA-pathway development. The exclusion raises due process and APA concerns that could imperil the final rule.
Source: saltlakecitysun.com · memphissun.com
Duane Boise is linked from 6 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
